Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Division of Cardiology, Daqing Oilfield General Hospital, Daqing, China.
Am Heart J. 2021 Apr;234:101-110. doi: 10.1016/j.ahj.2021.01.011. Epub 2021 Jan 16.
Double kissing (DK) crush approach for patients with coronary bifurcation lesions, particularly localized at distal left main or lesions with increased complexity, is associated with significant reduction in clinical events when compared with provisional stenting. Recently, randomized clinical trial has demonstrated the net clinical benefits by intravascular ultrasound (IVUS)-guided implantation of drug-eluting stent in all-comers. However, the improvement in clinical outcome after DK crush treatment guided by IVUS over angiography guidance for patients with complex bifurcation lesions have never been studied in a randomized fashion.
DKCRUSH VIII study is a prospective, multicenter, randomized controlled trial designed to assess superiority of IVUS-guided vs angiography-guided DK crush stenting in patients with complex bifurcation lesions according to DEFINITION criteria. A total of 556 patients with complex bifurcation lesions will be randomly (1:1 of ratio) assigned to IVUS-guided or angiography-guided DK crush stenting group. The primary end point is the rate of 12-month target vessel failure, including cardiac death, target vessel myocardial infarction, or clinically driven target vessel revascularization. The secondary end points consist of the individual component of primary end point, all-cause death, myocardial infarction, and in-stent restenosis. The safety end point is the incidence of definite or probable stent thrombosis. An angiographic follow-up will be performed for all patients at 13 months and clinical follow-up will be continued annually until 3 years after the index procedure.
DKCRUSH VIII trial is the first study designed to evaluate the differences in efficacy and safety between IVUS-guided and angiography-guided DK crush stenting in patients with complex true bifurcation lesions. This study will also provide IVUS-derived criteria to define optimal DK crush stenting for bifurcation lesions at higher complexity.
与临时支架相比,对于冠状动脉分叉病变患者,尤其是对于远端左主干或复杂性增加的病变,采用双吻(DK)挤压技术具有显著降低临床事件的作用。最近,随机临床试验已经证明,在所有患者中,使用血管内超声(IVUS)指导药物洗脱支架植入可带来净临床获益。然而,对于复杂分叉病变患者,DK 挤压治疗在 IVUS 指导下与血管造影指导相比,其临床结果的改善从未在随机试验中进行过研究。
DKCRUSH VIII 研究是一项前瞻性、多中心、随机对照试验,旨在根据 DEFINITION 标准评估 IVUS 指导与血管造影指导下 DK 挤压支架置入术治疗复杂分叉病变患者的优越性。共有 556 例复杂分叉病变患者将被随机(1:1 比例)分配到 IVUS 指导或血管造影指导 DK 挤压支架置入组。主要终点是 12 个月时靶血管失败的发生率,包括心脏死亡、靶血管心肌梗死或临床驱动的靶血管血运重建。次要终点包括主要终点的各个组成部分、全因死亡、心肌梗死和支架内再狭窄。安全性终点是确定或可能的支架血栓形成的发生率。所有患者将在 13 个月时进行血管造影随访,临床随访将继续每年一次,直到索引手术后 3 年。
DKCRUSH VIII 试验是第一项旨在评估 IVUS 指导与血管造影指导下 DK 挤压支架置入术治疗复杂真性分叉病变患者的疗效和安全性差异的研究。该研究还将提供基于 IVUS 的标准,以定义更高复杂性分叉病变的最佳 DK 挤压支架置入术。